Saturday, March 29, 2014

Psychiatric Disorders, Diseases, and Drugs




“The emptiness of the depression turns to grief, then to numbness and back again. My world is filled with underwater voices, people, [and] lists of things to do. They gurgle and dart in and out of my vision and reach. But they are so fast and slippery that I can never keep up. . . . All escapes are illusory—distractions, sleep, drugs, doctors, answers, hope . . .” (Manning, M, 1995, p. 99).  Psychological disorders and diseases have such a huge impact on the day-to-day lives of those who suffer from them; they involve severe cases of psychological impairment.  According to Pinel (2009) some cases are “influenced more by experiential factors …” (Pinel, 2009, p. 456).  When discussing psychological disorders (e.g. schizophrenia, depression, mania, anxiety disorders, and Tourette syndrome) there are many items to consider, such as, associated theories of the disorder and what, if any, are the treatments for the disorder.
Hallucinations (e.g. hearing voices) are only one symptom of schizophrenia.  The difficulty in diagnosing schizophrenia, according to Pinel (2009), is that the symptoms are quite diverse and mirror other psychiatric disorders.  Other diagnostic symptoms include delusions, inappropriate affect (e.g. laughing at funerals, shouting in church), incoherent thought, and odd behavior (e.g. statuesque poses, echolalia).  According to Hao-Yan Tan, Joseph Callicott, and Daniel Weinberger (2009) “Schizophrenia has complex genetic heritability” (p. 277, para. 1).  One of the first psychoactive drugs identified and used for the treatment of schizophrenic symptoms was Chlorpromazine.  One of a high affinity antischizophrenic drug, within the phenothiazine chemical class; all bind to the D1 and D2 receptors inhibiting dopamine receptors (Pinel, 2009; Tan, Callicott, & Weinberger, 2009).  Low affinity drugs such as haloperidol and spiroperidol, indicates Pinel (2009), are within the butyrophenone chemical class, and bind only to the D2 receptors, which play a role in the cause of schizophrenia.  According to Tan, Callicott, and Weinberger (2009) D2 receptors are crucial for cognitive processes; thus the dopaminergic systems are finely tuned for effective information processing.  Although it takes several weeks for any of the anti-schizophrenic drugs to take effect, there are a high percentage of patients who cease taking his or her medication because of the side effects (e.g. diabetes, weight gain) (Pinel, 2009).   The effects on cognitive functioning need to be better understood, as do the experiential contributions to the disease.  Current theories of treatment center on the dopamine system; where psychoactive drugs act as receptor blockers at the dopamine synapses.
One cannot go through life without experiencing the loss of a loved one, the loss of a job, or an illness that makes him or her have a deep emotional sadness (reactive depression).  However, there are those that repeatedly experience deep emotional distress for no reason (endogenous depression), but when that depression is to the point he or she cannot function in a daily capacity; this is the definition of clinical depression (Pinel, 2009).  Depression and mania are both psychotic disorders of emotion; during periods of mania an individual will experience extreme bursts of energy, impulsiveness, and over confidence.  Although a manic appears to have endless energy and drive, disaster typically trails his or her path.  When depression is combined with mania, it is known as bipolar affective disorder or manic depression, and depression with no mania is known as unipolar affective disorder (Pinel, 2009).  Whether the environment (e.g. stress) triggers a genetic emotional state or a genetic emotional state triggers an environmental state of stress may never be answered; however, Pinel indicates (2009), seasonal affective disorder (SAD) is an environmental condition known to trigger depression in individuals by depleting sunlight.  Although SAD typically dissipates when the shorter winter days give way to summer, light therapy has also proven helpful in reducing symptoms.  Whereas, treating other affective disorders has been through a series of antidepressant drugs: “monoamine oxidase [MOA] inhibitors, tricyclic antidepressants, lithium, and selective monoamine-reuptake inhibitors [SSRI’s]” (Pinel, 2009, p. 463).  MOA inhibitors are used for depression but have serious side effects when combined with foods rich in tyramine (e.g. cheese, wine, pickles); possible risks include stroke caused by surges in blood pressure.  Tricyclic antidepressants work by blocking the reuptake of both serotonin and norepinephrine, increasing levels of both in the brain and are, according to Pinel (2009), safer than MAO inhibitors.  Lithium is used in the treatment of bipolar affective disorder; it works as a mood stabilizer blocking the rapid shifts between depression and mania.  SSRI’s are used for treating depression.  According to Pinel (2009) the popularity of SSRI’s is twofold “first, they have few side effects [and] second, they are effective against a wide range of psychological disorders in addition to depression” (p. 464).  Associated theories of affective disorders include the monoamine theory and the diathesis-stress model theory.  The monoamine theory implicates a deficit in monoamine release, whereas the diathesis-stress model implicates a genetic susceptibility. 
“Anxiety is a chronic fear that persists in the absence of any direct threat;” however, when that fear becomes so severe it disrupts daily activities it is known as anxiety disorder (Pinel, 2009, p. 466).  Anxiety disorders are classified into five categories: generalized, phobic, panic, obsessive-compulsive (OCD), and posttraumatic stress (PTSD).  Generalized anxiety is the presence of fear or stress in the absence of a precipitating stimulus, unlike phobic anxiety where an object (e.g. spider, snake) or situation (e.g. plan ride, crowd) is the stimulus of the anxiety.  Panic disorders occur rapidly with severe symptoms of stress (e.g. racing heart, sweating) and can be associated or separate from generalized or phobic disorders.  OCD is characterized by its name; whereas, the affected person is obsessed by thoughts and impulses.  He or she responds to these impulses, for example, by repeatedly cleaning the house or locking and unlocking the door.  PTSD is a serious condition that can develop after a person has experienced or witnessed a traumatic or terrifying event such as war or sexual assault.  Anxiety disorders are treated slightly different from affective disorders, with the use of antidepressants (SSRI’s), benzodiazepines, and serotonin agonists.  Because SSRI’s are known for their multipurpose use they are often affective on anxiety disorders as well as depression.  Benzodiazepines, more commonly known as Librium and Valium are widely prescribed to treat anxiety.  Side effects include sedation, nausea, withdrawal reaction, and rebound anxiety as benzodiazepines are highly addictive.  Serotonin agonist affects the 5-HT1A receptor, unlike an SSRI, to produce anti-anxiety, although its side effects are different from that of benzodiazepines producing “dizziness, nausea, headache, and insomnia” (Pinel, 2009, p. 468).  Current theories on anxiety disorder focus on the amygdala, prefrontal lobes, and cognitive factors (Pinel, 2009).
Although someone that does not have Tourette syndrome may never know what it is like to go through life with an involuntarily motor or verbal tick (e.g. lewd gesture, hopping, barking, grunting, or worse), the person whom must live with this disorder is at the mercy of these ticks.  It is yet unknown if Tourette syndrome is genetic or environmental, although a family history increases the risk of developing Tourette’s.  Treatment has been through education, psychotherapy for anxiety and depression, and deep brain stimulation (which has shown promising results).  Medication such as neuroleptics, a D2 receptor blocker are provided to treat symptoms related to conditions such as ADHD and OCD; currently response to treatment is moderate (Pinel, 2009; Mayo Clinic, 2010).  Additional theories are leaning toward the hypothesis that Tourette syndrome is a neurodevelopmental disorder…
Just as those who suffer from psychological disorders such as schizophrenia, affective disorders, anxiety disorders, and Tourette syndrome fight to find the normalcy in his or her daily life, there is someone struggling to understand what he or she is going through to improve upon those challenges.  The more that can be understood both physically and psychologically about each of these disorders and diseases, the closer society will come to producing a solution that will treat and possibly cure each psychological disorder that plagues the depths of the mind and body.  A slow and arduous task that cures one ailment while causing another; making it impossible to take at times.  However, our hope for a cure lays in the future, every evolving and every changing.

 

No comments:

Post a Comment